MEDICENNA THERAPEUTICS CORP (MDNA.CA) Stock Income Statement
TSX:MDNA - Toronto Stock Exchange - CA58490H1073 - Common Stock - Currency: CAD
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 20.41M | 18.67M | 16.30M | 22.47M | 17.40M | |||
| Research and Development | 14.44M | 10.80M | 9.30M | 16.47M | 10.87M | |||
| Selling, General, and Administrative Expenses | 5.91M | 7.87M | 6.99M | 7.72M | 6.49M | |||
| Operating Income | -20.41M | -18.67M | -16.30M | -22.47M | -17.40M | |||
| Interest Income/Expense | 8.60M | -6.79M | 6.26M | -100.00K | 110.00K | |||
| Other Income/Expense | N/A | 0.00 | N/A | 104.00K | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -11.80M | -25.47M | -10.05M | -22.58M | -17.29M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -11.80M | -25.47M | -10.05M | -22.58M | -17.29M | |||
| EBITDA | -20.35M | -18.67M | N/A | -22.43M | -17.36M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.15 | -0.37 | -0.16 | -0.42 | -0.35 | |||
| Non GAAP EPS | -0.15 | -0.36 | -0.19 | -0.42 | -0.35 | |||
| Statistics | ||||||||
All data in CAD